NanoViricides Inc (NNVC)

Name: NanoViricides Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$1.8M

Operating Margin

N/A

Free Cash Flow

-$8.5M

Debt / Assets

14.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for NanoViricides Inc (NNVC).
Income Statement (Quarterly)	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Revenue	0	0	0	0
Cost of Revenue	132,820	0	0	0
Gross Profit	-132,820	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	670,799	966,905	902,700	1,234,743
Operating Expenses	1,663,865	2,249,156	2,059,051	3,167,834
Operating Income	-1,796,685	-2,249,156	-2,059,051	-3,167,834
Interest Expense	0	0	149	0
Income Before Tax	-1,785,058	-2,216,783	-2,027,491	-3,126,811
Income Tax Expense	0	0	0	0
Net Income	-1,785,058	-2,216,783	-2,027,491	-3,126,811
Per Share
EPS	-0.10	-0.14	-0.14	-0.23
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for NanoViricides Inc (NNVC).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	0	0	0	0	0
Cost of Revenue	0	759,014	747,529	723,325	0
Gross Profit	0	-759,014	-747,529	-723,325	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	4,042,544	3,078,814	2,551,054	2,328,737	2,629,565
Operating Expenses	9,591,645	8,516,111	8,943,468	8,113,599	8,744,106
Operating Income	-9,591,645	-8,516,111	-8,943,468	-8,113,599	-8,744,106
Interest Expense	0	49,808	938	5,123	85,405
Income Before Tax	-9,466,966	-8,294,146	-8,588,573	-8,106,863	-8,822,189
Income Tax Expense	0	0	355,833	-6,736	0
Net Income	-9,466,966	-8,294,146	-8,588,573	-8,100,127	-8,822,189
Per Share
EPS	-0.63	-0.70	-0.74	-0.70	-0.81
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for NanoViricides Inc (NNVC).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	1,558,564	4,797,778	8,149,808	14,066,359
Short Term Investments	0	0	0	0
Net Receivables	0	0	0	0
Inventory	0	0	0	0
Total Current Assets	1,670,710	4,970,520	8,445,294	14,416,380
Property Plant Equipment	6,833,891	7,512,463	8,106,647	8,694,194
Goodwill and Intangibles	317,039	325,308	333,578	341,848
Total Assets	8,824,085	12,822,853	16,899,880	23,494,862
Liabilities
Account Payables	1,280,550	376,270	157,056	57,960
Short Term Debt	0	0	0	94,788
Total Current Liabilities	1,306,519	1,358,776	534,250	412,837
Long Term Debt	0	0	0	0
Total Liabilities	1,306,519	1,358,776	2,034,250	412,837
Shareholders Equity
Retained Earnings	-148,841,861	-139,374,895	-131,080,749	-122,492,176
Total Shareholders Equity	7,517,566	11,464,077	14,865,630	23,082,025

Balance sheet annual history for NanoViricides Inc (NNVC).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	1,558,564	4,797,778	8,149,808	14,066,359	20,516,677
Short Term Investments	0	0	0	0	0
Net Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Total Current Assets	1,670,710	4,970,520	8,445,294	14,416,380	20,823,779
Property Plant Equipment	6,833,891	7,512,463	8,106,647	8,694,194	9,084,901
Goodwill and Intangibles	317,039	325,308	333,578	341,848	350,118
Total Assets	8,824,085	12,822,853	16,899,880	23,494,862	30,262,313
Liabilities
Account Payables	1,280,550	376,270	157,056	57,960	231,555
Short Term Debt	0	0	0	94,788	95,306
Total Current Liabilities	1,306,519	1,358,776	534,250	412,837	351,146
Long Term Debt	0	0	0	0	0
Total Liabilities	1,306,519	1,358,776	2,034,250	412,837	351,146
Shareholders Equity
Retained Earnings	-148,841,861	-139,374,895	-131,080,749	-122,492,176	-114,385,313
Total Shareholders Equity	7,517,566	11,464,077	14,865,630	23,082,025	29,911,167

Cash flow quarterly history for NanoViricides Inc (NNVC).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-9,466,966	-8,294,146	-8,588,573	-8,106,863
Depreciation & Amortization	743,805	759,014	747,529	723,325
Stock Based Compensation	223,347	222,185	214,179	338,418
Change in Working Capital	20,456	996,877	1,798,815	214,563
Operating Cash Flow	-8,478,679	-6,315,507	-5,670,051	-5,891,254
Investing Activities
Capital Expenditure	-56,964	-156,560	-151,712	-324,348
Investments	-56,964	-156,560	-151,712	-324,348
Investing Cash Flow	-56,964	-156,560	-151,712	-324,348
Financing Activities
Debt Repayment	0	0	-94,788	-234,716
Common Stock Issued/Repurchased	5,296,429	3,120,037	0	0
Dividends Paid	0	0	0	0
Financing Cash Flow	5,296,429	3,120,037	-94,788	-234,716
Summary
Free Cash Flow	-8,535,643	-6,472,067	-5,821,763	-6,215,602
Net Change in Cash	-3,239,214	-3,352,030	-5,916,551	-6,450,318

Cash flow annual history for NanoViricides Inc (NNVC).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-9,466,966	-8,294,146	-8,588,573	-8,106,863	-8,822,189
Depreciation & Amortization	743,805	759,014	747,529	723,325	704,538
Stock Based Compensation	223,347	222,185	214,179	338,418	405,594
Change in Working Capital	20,456	996,877	1,798,815	214,563	-540,112
Operating Cash Flow	-8,478,679	-6,315,507	-5,670,051	-5,891,254	-8,213,837
Investing Activities
Capital Expenditure	-56,964	-156,560	-151,712	-324,348	-238,764
Investments	-56,964	-156,560	-151,712	-324,348	-238,764
Investing Cash Flow	-56,964	-156,560	-151,712	-324,348	-238,764
Financing Activities
Debt Repayment	0	0	-94,788	-234,716	-1,303,013
Common Stock Issued/Repurchased	5,296,429	3,120,037	0	0	16,563,697
Dividends Paid	0	0	0	0	0
Financing Cash Flow	5,296,429	3,120,037	-94,788	-234,716	15,260,684
Summary
Free Cash Flow	-8,535,643	-6,472,067	-5,821,763	-6,215,602	-8,452,601
Net Change in Cash	-3,239,214	-3,352,030	-5,916,551	-6,450,318	6,808,083